Erythropoietin for treating post-ivermectin Loa-related serious adverse events?
Boussinesq
Michel
M
Kamgno
Joseph
J
Pion
Sébastien D
SD
Mackenzie
Charles D
CD
D000871:Anthelmintics / Q000009:adverse effects* / Q000627:therapeutic use; D004921:Erythropoietin / Q000494:pharmacology*; D006801:Humans; D007559:Ivermectin / Q000009:adverse effects* / Q000627:therapeutic use; D008118:Loiasis / Q000188:drug therapy*; D018696:Neuroprotective Agents / Q000627:therapeutic use*
D000871:Anthelmintics; D018696:Neuroprotective Agents; D004921:Erythropoietin; D007559:Ivermectin